
Azelaic Acid: Treats acne and rosacea bumps; may also help uneven pigmentation. Mandelic Acid: Exfoliates skin; clinical evidence is mainly from professional acne peels.


Choose for acne or rosacea bumps, especially when uneven tone is also a concern.
Consider for exfoliation; evidence for acne comes mainly from supervised peels.
Can you use both?
Both exfoliate gently but can sting together. Alternate nights.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Helps calm inflammation: Acts on pathways involved in acne and rosacea. Affects pigment production: Tyrosinase-related activity may help dark marks.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Loosens outer cells: An acidic formula helps reduce cell adhesion. Promotes shedding: Strength, pH and contact time affect the response.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Azelaic acid strength should be read together with the product’s indication. Prescription examples include 15% gel for inflammatory rosacea and 20% cream for acne.
15%
20%
Prescription rosacea formulation
Gel formulations are labeled for inflammatory papules and pustules of rosacea. They are not simply a weaker version of a 20% acne cream.
Prescription acne cream
A cream strength used for acne. The cream base and indication differ from the 15% rosacea gel.
Choosing a strength: Choose by the concern and finished product. Cosmetic azelaic acid products are not automatically equivalent to prescription formulations.
Higher strengths: Stinging and irritation can limit use. A larger number does not prove better delivery or better results for a different diagnosis.
Formula matters: Gel, foam and cream vehicles affect delivery and tolerability. Do not compare their percentages as if they were identical formulations.
Mandelic acid skincare and office peels are different products. Controlled acne studies have used professional peels around 40–45%; those strengths are not a target for facial home use.
40–45%
Studied professional peels
Clinician-applied peels studied for mild-to-moderate acne. This describes specific procedures, not a recommended home concentration.
Choosing a strength: For home skincare, use the finished product’s label and your tolerance. Do not assume that a marketed serum reproduces an office peel study.
Higher strengths: Mandelic acid can still burn or irritate skin. Being described as a gentler acid does not make concentrated peels suitable for unsupervised use.
Formula matters: Acidity, vehicle and exposure time influence the effect; percentage alone cannot rank safety or compare mandelic acid with other acids.
Approximate windows, not promises.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Stinging, itching and dryness can occur; reduce use for persistent irritation.
Can cause stinging, peeling or irritation; avoid active eczema and rosacea flares.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
It is the usual first choice. Very little is absorbed through the skin, it has a long record, and it is what dermatologists switch people to when retinoids stop. Confirm with the doctor managing your pregnancy.
Low-strength leave-on acids are generally considered acceptable; avoid peels and ask the clinician managing your pregnancy.
On the skin. The finished product delivers azelaic acid in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Acts on inflammation, acne-related bacteria and pigment pathways; it is not simply an exfoliating peel.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers mandelic acid in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Promotes shedding of surface cells; formula acidity and contact time influence irritation and effect.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Choose for acne or rosacea bumps, especially when uneven tone is also a concern.
Two large vehicle-controlled trials support 15% gel for papulopustular rosacea. Acne has guideline support, but a 10% cosmetic serum should not be assumed equivalent to a studied prescription formula.
Consider for exfoliation; evidence for acne comes mainly from supervised peels.
A 50-person, 12-week trial compared 45% mandelic with 30% salicylic peels. It had no vehicle arm and does not establish the benefit of 5–10% home serums.
Sources